Inovio inventory forecast 2025 refers back to the predicted worth of Inovio Prescribed drugs’ (INO) inventory in 2025. Inventory forecasts are primarily based on varied elements akin to the corporate’s monetary efficiency, business tendencies, and total financial situations.
Inovio is a clinical-stage biotechnology firm centered on creating and commercializing DNA-based immunotherapies for infectious ailments and most cancers. The corporate’s lead product candidate, INO-4800, is a DNA vaccine for COVID-19 that’s presently in Part 3 scientific trials. Inovio additionally has a pipeline of different DNA-based vaccines in growth for varied infectious ailments and most cancers indications.
